Trade BioNTech BNTX

Sell
 Buy

BioNTech live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

BioNTech News

Ghko B 2025 Sep 22, 16:00

Bitcoin, Ethereum Price Prediction: Will BTC/USD, ETH/USD Continue to Rise?

crypto
Ghko B 2025 Sep 22, 16:00

NIO stock prediction: How much will NIO stock be worth in 2030?

stocks
Ghko B 2025 Sep 22, 16:00

Trending AI Stocks to Watch: C3.ai Inc (NYSE: AI), Datavault AI (DVLT) Stock

stocks
Ghko B 2025 Sep 22, 16:00

AI Chip Stocks Comparison: Nvidia (NVDA) Stock, AMD Stock, Intel Stock

stocks
Frances Wang 2025 Sep 21, 16:00

QBTS Stock Climbs 11% Today: What’s Happening with D-Wave Quantum Inc?

stocks
Tommy Yap 2025 Mar 04, 16:00

Week Ahead: U.S. Inflation Data and BoC Policy Rate in Focus

Forex Indices
Moderna Share Price
Georgy Istigechev 2024 Jan 03, 08:01

Moderna share price jumps as Oppenheimer upgrades stock

Shares
Pfizer shares sink as revenue prospects
Georgy Istigechev 2023 Dec 14, 05:13

Pfizer shares sink on lower COVID revenue prospects

Shares
shutterstock_1781525795.jpg
Zachariah Walker 2023 Feb 14, 09:11

5 Stocks to Fall in Love with this Valentines Day

2021 Aug 24, 08:05

Stocks make further gains as oil bounce carries on

Latest news

Show more
Emma Rose 2025 Sep 23, 03:20

Wall Street Eyes Powell for Fed Rate Cut Clues Amid Market Highs

Sophia Claire 2025 Sep 23, 02:20

Saudi-Pakistan Defense Pact: Unlikely to Disrupt India's Energy Ties

Ava Grace 2025 Sep 23, 01:20

Fed Independence Under Scrutiny: Trump's Legal Battle and Potential Ramifications

Emma Rose 2025 Sep 22, 15:20

Gold & Silver Surge: Citi Foresees Broader Metals Rally Ahead

Ava Grace 2025 Sep 22, 15:20

Musalem: Cautious Approach to Further Rate Cuts Amid Inflation Concerns

Ava Grace 2025 Sep 22, 09:20

US Investors Hoarding Cash Despite Looming Rate Cuts: A Deep Dive

Liam James 2025 Sep 22, 09:20

France and Saudi Arabia Push for Palestinian Recognition: Will the Two-State Solution Gain Momentum?

Noah Lee 2025 Sep 22, 08:20

Hayashi: BOJ's Rate Hike Plans Align with Government's Economic Policy

Info

Spread

0.9814

Spread (%)

1.0007 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Tuesday

13:31 - 19:59

Monday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

23131164672

Shares Outstanding

240398724

Earnings Date (Next)

0000-00-00

Div Yield

2022-06-17

Ex-Dividend Date

2022-06-02

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-1.69

Learn more about this instrument

BioNTech BioNTech SE
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical trial for solid tumors; BNT152+BNT153, which is in phase 1 clinical trial for solid tumors; and BNT122/RO7198457, which is in Phase 2 clinical trial to treat adjuvant high-risk muscle-invasive urothelial carcinoma, colorectal cancer, pancreatic ductal adenocarcinoma, advance melanoma, as well as in phase 1a/1b clinical trial for advanced/metastatic solid tumors. It also develops BNT211, which is in phase 1 clinical trial to treat CLDN6+ solid tumors; BNT221, phase 1 clinical trial for the treatment of cancer; BNT311/GEN1046 (acasunlimab), which is in phase 3 clinical trial for solid tumors; BNT312/GEN1042, which is in phase 1/2 and 1 clinical trial to treat solid tumors; BNT314/GEN1059, which is in Phase 1/2 clinical trial for advanced or metastatic solid tumors; BNT315/GEN1055, which is in phase 1/2 clinical trial for advanced solid tumors; BNT317, which is in phase 1 clinical trial for advanced solid tumors; BNT327, which is in phase 1/2, 2, and 3 clinical trial to treat small cell lung cancer, advanced/metastatic tnbc, neuroendocrine neoplasm, malignant mesothelioma, EGFR-mutant non-squamous, hepatocellular carcinoma, and advanced solid tumors; and BNT316/ONC-392, which is in phase 1/2, 2, and 3 clinical trial to treat metastatic, non-small cell lung cancer, platinum-resistant ovarian cancer, metastatic castration resistant prostate cancer, and advanced or metastatic solid tumor. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Frances Wang 2025 Sep 21, 16:00

Gold Price (XAU/USD) Is over $3,714: How to Trade Gold CFDs in Saudi Arabia?

Commodities CFD Trading
Frances Wang 2025 Sep 21, 16:00

How to Invest in Crypto Market in KSA: BTC CFD, ETH CFD, XRP CFD, SOL CFD

Stocks
Frances Wang 2025 Sep 21, 16:00

Active CFD Brokers in the Middle East: markets.com, IG, AvaTrade

CFD Trading
Trustpilot